Home/Filings/4/0000950170-25-096947
4//SEC Filing

Metzger Michael A 4

Accession 0000950170-25-096947

CIK 0001395937other

Filed

Jul 17, 8:00 PM ET

Accepted

Jul 18, 4:30 PM ET

Size

4.7 KB

Accession

0000950170-25-096947

Insider Transaction Report

Form 4
Period: 2025-07-16
Metzger Michael A
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2025-07-16$9.29/sh7,534$69,953298,661 total
Footnotes (1)
  • [F1]Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.

Documents

1 file

Issuer

Syndax Pharmaceuticals Inc

CIK 0001395937

Entity typeother

Related Parties

1
  • filerCIK 0001507220

Filing Metadata

Form type
4
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 4:30 PM ET
Size
4.7 KB